Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Ocular Therapeutix (OCUL) is now available.
Ocular Therapeutix, Inc. has appointed its seasoned executive, Donald Notman, as Chief Operating Officer, while he will also retain his roles as Chief Financial Officer and principal financial and accounting officer. Notman brings a wealth of experience from previous senior positions in the biopharmaceutical industry and investment banking, underscoring his financial acumen and leadership skills. His educational background includes a B.A. in Economics and an M.B.A., adding to his strong profile as he steps into this dual role without any related party transactions or familial conflicts of interest.
For an in-depth examination of OCUL stock, go to TipRanks’ Stock Analysis page.